HealthTech and MedTech M&A Advisors
Nelson Advisors specialise in Mergers and Acquisitions, Partnerships and Investments for HealthTech, MedTech, Digital Health, Health IT, Consumer HealthTech, Healthcare AI companies based in the UK, Europe and North America Nelson Advisors LLP, Hale House, 76-78 Portland Place, London, W1B 1NT
European HealthTech and MedTech Investment Banking
Mergers & Acquisitions, Partnerships & Investments
'Build, Buy, Partner, Sell'
Nelson Advisors specialise in mergers and acquisitions, partnerships and investments for MedTech, Digital Health, HealthTech, Health IT, Consumer HealthTech, Healthcare AI companies. Our team of successful healthcare technology founders and senior execs have built and scaled HealthTech businesses since 2012, securing exits from US, European and FTSE listed companies. We work with our UK, European and North American clients to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value and investment returns..
Our Founding Partners have personally built, scaled and exited 4x HealthTech businesses in the Patient Engagement, Medical Device Cybersecurity, Metabolic Health and Consumer Health markets. In addition to founding HealthTech businesses, they have served on a wide range of company boards ranging from Digital MSK to Community Workforce Management to Wearable Tech to Healthcare AI to D2C Healthcare.
'We pride ourselves on our DNA as Founder Bankers advising Founders'
Mergers & Acquisitions
Buy Side
Sell Side
Corporate Divestitures
Portfolio Optimisation
Roll Up Strategies
Tech Asset Sales
Series A Exits
Partnerships & Investments
Go To Market
UK Market Entry
International Expansion
Channel Partnerships
Joint Ventures
Commercial Due Diligence
Fundraising Strategies
HealthTech and MedTech > Mergers and Acquisitions
Nelson Advisors offers a comprehensive suite of M&A services tailored to various client needs, from strategic acquisitions to exits:
Buy-Side Advisory: Nelson Advisors assists clients in identifying, evaluating, and acquiring target companies that align with their strategic objectives.
Sell-Side Advisory: Nelson Advisors guides companies through the intricate process of selling their businesses.
Corporate Divestitures: Advisory services are provided for the sale of non-core assets or business units.
Roll-Up Strategies: Nelson Advisors supports clients in executing strategies that involve acquiring multiple smaller companies.
Strategic Partnerships & Investment Advisory
Beyond traditional M&A, Nelson Advisors provides advisory services focused on growth, market expansion and investment strategies:
Go-To-Market Strategies: Nelson Advisors assists companies in planning and executing launching new products into new markets.
UK Market Entry: Specific expertise is offered for companies looking to establish or expand their presence within the UK healthcare market.
International Expansion: Guidance extends to broader international growth strategies beyond the UK, reflecting a global perspective.
Channel Partnerships: Advisory services include forming strategic alliances to leverage partners' distribution networks or complementary services.
Nelson Advisors > Founding Partners
Founding Partners Lloyd Price and Paul Hemings are supported by a team of Analysts and VP’s with backgrounds and experience ranging from Rothschild, Citi and Morgan Stanley to ETH Zurich, Kieger and redalpine. The Nelson Advisors team combine strong academic achievements with MBA's, PhD's and MSc's combined with decades of investment banking experience, financial analysis, investor relations and entrepreneurial ventures. Our Founding Partners have built, scaled and exited 4x HealthTech businesses since 2012. Exits were secured in the Patient Engagement, Medical Device Cybersecurity, Metabolic Health and Consumer Healthcare markets. Lloyd and Paul both regularly mentor MBA students, guest lecture and speak at leading University Business Schools across Europe including University College London Global Business School for Health, Oxford University, University of Cambridge, London Business School and IESE Business School, Barcelona.
Lloyd Price
Lloyd is a Partner and Co-Founder of Nelson Advisors. He brings 12+ years of successful HealthTech entrepreneurial experience having founded and exited various Healthcare Technology companies including Zesty in 2020 to Induction Healthcare Group PLC (FTSE:INHC).
Prior to his HealthTech ventures, Lloyd held senior business development, marketing, strategy and corporate development roles at Kelkoo, Yahoo! Europe and Badoo from 2000 to 2012.
Lloyd is a Health Executive in Residence at the UCL Global Business School for Health, Mentor for Oxford Venture Capital Network and Oxford MedTech Society. He was a Founder of The Future Health community in 2024 and Founding Member of the Digital Healthcare Council in 2017.
He led the Coadec-TechUK delegations sent to the European Parliament in Brussels in Sept 2015 and March 2016 to discuss the General Data Protection Regulation and EU Digital Single Market.
Lloyd was asked to judge the Digital Health PitchFest Awards in 2022, 2023, HealthInvestor Awards in 2024, 2025, Healthcare Summit Awards 2025 and Digital Health Awards at HLTH 2025.
He is a Non Executive Director and Advisor for various UK Digital Health companies.
HealthTech Exits > 2020 and 2024
Paul Hemings
Paul is a Partner and Co-Founder of Nelson Advisors. He brings more than a decade of global M&A and capital raising expertise, and 10 years of entrepreneurial experience having founded and exited from 2 early-stage companies, most recently in metabolic HealthTech.
Prior to his early-stage ventures, Paul held investment and strategy roles at Invesco, and senior investment banking advisory roles at Credit Suisse where his transaction experience included over £50 Billion of M&A and £40 Billion of equity/financing.
Paul remains an active Board Advisor to a number of early-stage tech companies across the health/med tech, fintech and consumer sectors. Paul has an honours degree in Economics from Queen’s University (Canada) and an MBA from London Business School.
His extensive corporate finance experience includes $50+ Billion of Mergers & Acquisitions and $40+ Billion equity/financing transactions across US, UK, Ireland, Sweden, Denmark, Switzerland, Germany, Austria, Italy, Poland, Ukraine, Russia, Kazakhstan, Hong Kong, Singapore and Australia.
As Co-Founder of Neutrally, Paul focused on intercepting chronic lifestyle disease with data-led habit change around nutrition, exercise, sleep + mental well-being. His research led to the commercial application of the future of weight management, wellness & longevity.
HealthTech Exits > 2019 and 2024
Contact Us:
Fill out the contact form below to get in touch with our team. We are here to answer any questions and provide assistance for all your corporate development needs.
Message Us:
You can also send us a secure and confidential message on Signal.
nelsonadvisors.41